Dose-effect relationship of aramine in the treatment of hypotension after cesarean section under lumbar anesthesia

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2200064362

Enrollment

Unknown

Registered

2022-10-04

Start date

2022-10-01

Completion date

Unknown

Last updated

2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hypotension after cesarean section under lumbar anesthesia

Interventions

A1:0.2mg aramine

A2:0.3mg aramine

A3:0.4mg aramine

A4:0.5mg aramine

A5:0.6mg aramine

Eligibility

Sex/Gender

Female

Age

18 Years to 40 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: A total of 100 pregnant women who underwent cesarean section, full term, singleton pregnancy, ASA class I or II, body mass index 20-35kg/m2, height 150-175cm, weight 50-100kg were selected.

Exclusion criteria

Exclusion criteria: Exclusion criteria were fetal abnormalities, presence of hypertension or hypertensive disorders during pregnancy, cardiovascular or cerebrovascular diseases, bradycardia or other types of arrhythmias, contraindications to spinal anesthesia, m-hydroxyamine, and allergy to local anesthetics.

Design outcomes

Primary

Measure	Time frame
blood pressure;heart rate;1min Apgar;5min Apgar;Umbilical artery blood gas;	—

Countries

China

Contacts

Public ContactHong-shu Shi

Linping District Maternaity and Child Care Hospital

565532360@qq.com15155365737

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026